Home /
Impact
Since 2022, BrainPOP has grown from program establishment to a proven clinical trials and precision medicine platform.
BrainPOP’s impact is measured not just in scale, but in the quality and specificity of the evidence generated – evidence that directly answers whether treatments reach their target and what effect they have.
650+
Patients reached across clinical trials and research programs
400+
Patients have comprehensive tumour profiling
6
Perioperative clinical trials delivered and in pipeline
4
Industry sponsored trials supported
15+
Peer-reviewed publications
$30 M
Leveraged funding from competitive grants, philanthropy and industry partners
The BrainPOP program is led by The Brain Cancer Centre and delivered in collaboration with The Royal Melbourne Hospital, Peter MacCallum Cancer Centre, University of Melbourne, The Royal Children’s Hospital, Murdoch Children’s Research Institute and WEHI, supported by investment from the Victorian Government.
